Total Funding
59
57
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61060
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
- Joseph Payne: President and CEO
- Pad (Padmanabh) Chivukula: Founder, CSO & COO
About the Company
Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome.
It was
founded in 2013 and is headquartered in San Diego, California.
